How I Improved My Organization in One Day by Using this Top Companies in Diagnostic Biomarkers Market Article

Diagnostic Biomarkers Market Anticipated to Reach USD 95.1 Billion by 2028.

How I Improved My Organization in One Day by Using this Top Companies in Diagnostic Biomarkers Market Article

Market Overview:

According to Vantage market research, the Global Diagnostic Biomarkers market is valued at USD 45.9 Billion in 2021 and is projected to attain a value of USD 95.1 Billion by 2028 at a CAGR of 12.1% during the forecast period, 2022–2028. A diagnostic biomarker is a part of a biological parameter that provides a diagnosis of a disease. It is used to determine the success of treatment or disease progression. These procedures can be performed in any of the findings such as genetic, physiological, laboratory, anatomical, radiological, or other finding to bifurcate one disease from other.

Biomarkers are integrated with high data management technologies and key imaging, thus they fulfill the need for early diagnosis and meeting market expectations. Therefore it is responsible for augmenting the growth of the Diagnostic Biomarkers Market in coming years. In addition, advanced omics technologies provide analysis and identification of mutations & polymorphisms in key genes. Thus, it increases demand for genomic biomarkers and further boosts market demand.

Following are the top 10 leading companies in the Diagnostic Biomarkers market:

Company Name

Revenue in USD

  • F. Hoffmann-La Roche Ltd.

$68 Billion

  • Thermo Fisher Scientific Inc.

$39 Billion

  • Abbott Laboratories

$43 Billion


$1 Billion

  • PerkinElmer, Inc.

$3 Billion

  • Merck KGaA

$20 Billion

  • Bio-Rad Laboratories, Inc.

$2 Billion

  • Enzo Biochem, Inc.

$117 Million

  • Charles River Laboratories International, Inc.

$3 Billion

  • Eurofins Scientific

$5 Billion


  1. F. Hoffmann-La Roche Ltd.

Hoffmann-La Roche AG, commonly known as Roche, is a Swiss multinational healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. Its holding company, Roche Holding AG, has shares listed on the SIX Swiss Exchange. The company headquarters are located in Basel. Roche is the largest pharmaceutical company in the world and the leading provider of cancer treatments globally. The company controls the American biotechnology company Genentech, which is a wholly-owned affiliate, and the Japanese biotechnology company Chugai Pharmaceuticals, as well as the United States-based companies Ventana and Foundation Medicine. is organized into five major business areas: Roche Applied Science, Roche Professional Diagnostics, Roche Diabetes Care, Roche Molecular Diagnostics and Roche Tissue Diagnostics. All business areas except Roche Applied Science focus on health care applications, targeting either physicians, hospitals and clinics, or consumers. Applied Science targets research settings in academia and pharmaceutical and biotechnology industries.

  1. Thermo Fisher Scientific Inc.

Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. The company's mission is to enable their customers to make the world healthier, cleaner, and safer. The company supports its customers to accelerate life sciences research, solve complex analytical challenges, increase productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies. The company's global team delivers an unrivaled combination of innovative technologies, purchasing convenience, and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon, and PPD.

  1. Abbott Laboratories

Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States. The company was founded by Chicago physician Wallace Calvin Abbott in 1888 to formulate known drugs. The company sells medical devices, diagnostics, branded generic medicines, and nutritional products. Among its well-known products across the medical devices, diagnostics, and nutrition product divisions are Pedialyte, Similac, Ensure, Glucerna, ZonePerfect, FreeStyleLibre, i-STAT, and MitraClip.

  1. QIAGEN N.V.

QIAGEN is a German provider of sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research. Consolidated under the Dutch holding QIAGEN N.V., the company operates more than 35 offices in over 25 countries. The company delivers Sample to Insight solutions for molecular testing, propelling our customers from start to finish to unlock new insights. The company's product portfolio supports its customers across the continuum of molecular testing in molecular diagnostics and life sciences. From the first important step of DNA, RNA, and protein extraction from biological samples, to novel testing technologies targeting single or multiple molecular variants, and software to analyze and interpret molecular data to deliver valuable insights.

  1. PerkinElmer, Inc.

PerkinElmer, Inc. is an American global corporation focused on the business areas of diagnostics, life science research, food, environmental and industrial testing. Its capabilities include detection, imaging, informatics, and service. The company produces analytical instruments, genetic testing and diagnostic tools, medical imaging components, software, instruments, and consumables for multiple end markets. The company is a leading, global provider of end-to-end solutions that help scientists, researchers and clinicians better diagnose disease, discover new and more personalized drugs, monitor the safety and quality of their food, and drive environmental and applied analysis excellence. With an 85-year legacy of advancing science and a mission of innovating for a healthier world, the company's dedicated team of more than 16,000 collaborates closely with commercial, government, academic, and healthcare customers to deliver reagents, assays, instruments, automation, informatics, and strategic services that accelerate workflows, deliver actionable insights and support improved decision making.

  1. Merck KGaA

The Merck Group, branded and commonly known as Merck, is a German multinational science and technology company headquartered in Darmstadt, with about 57,000 employees and present in 66 countries. The group includes around 250 companies; the main company is Merck KGaA in Germany. The company is divided into three business lines: Healthcare, Life Sciences, and Electronics. Merck was founded in 1668 and is the world's oldest operating chemical and pharmaceutical company, as well as one of the largest pharmaceutical companies in the world.

  1. Bio-Rad Laboratories, Inc.


Bio-Rad Laboratories, Inc. is an American developer and manufacturer of specialized technological products for the life science research and clinical diagnostics markets. The company was founded in 1952 in Berkeley, California. The company is based in Hercules, California, and has operations worldwide. The company's life science products primarily include instruments, software, consumables, reagents, and content for the areas of cell biology, gene expression, protein purification, protein quantitation, drug discovery and manufacture, food safety, and science education. These products are based on technologies to separate, purify, identify, analyze, and amplify biological materials such as antibodies, proteins, nucleic acids, cells, and bacteria.

  1. Enzo Biochem, Inc.

Enzo Biochem is a leading life science and biotechnology company focused on harnessing genetic processes to develop research tools, diagnostics, and therapeutics and provides reference laboratory services to the medical community. Founded in 1976, the company has concentrated on the development of enabling technologies in the areas of gene regulation and gene modification. Many of the company's technologies are applicable to the biomedical and pharmaceutical research markets, and they are further using these technologies as a platform for their entry into the clinical diagnostics market. The company's products are recognized as the key tools in non-radioactive gene labeling used by researchers worldwide. Additionally, the company's works in gene analysis have led to the development of a number of significant therapeutic candidates for the treatment of viral and immunological based disorders, several of which are in various phases of human clinical trials. The company's activities include research and development, manufacturing and marketing of biomedical research products and tools through Enzo Life Sciences and research and development of therapeutic products through Enzo Therapeutics, and the operation of a regional clinical reference laboratory through Enzo Clinical Labs.

  1. Charles River Laboratories International, Inc.

Charles River Laboratories International, Inc., is an American pharmaceutical company specializing in a variety of preclinical and clinical laboratory, gene therapy, and cell therapy services for the Pharmaceutical, Medical Device, and Biotechnology industries. They also supply assorted biomedical products and outsourcing services for research and development in the pharmaceutical industry and offer support in the fields of basic research, drug discovery, safety and efficacy, clinical support, and manufacturing. Its customers include leading pharmaceutical, biotechnology, agrochemical, government, and academic organization around the globe. The company has over 90 facilities, operates in 20 countries, and employs approximately 18,400 people worldwide.

  1. Eurofins Scientific

Eurofins Scientific through its subsidiaries is the world leader in food, environment, pharmaceutical and cosmetic products testing, and agroscience CRO services. The company is also one of the global independent market leaders in testing and laboratory services for genomics, discovery pharmacology, forensics, advanced material sciences, and supporting clinical studies. In addition, Eurofins is one of the key emerging players in specialty esoteric and molecular clinical diagnostic testing in Europe and the USA. With 55,000 staff across a network of more than 1000 independent companies in over 50 countries and operating 900 laboratories, Eurofins offers a portfolio of over 200,000 analytical methods for evaluating the safety, identity, composition, authenticity, origin, and purity of biological substances and products, as well as for innovative clinical diagnostics. The main objective is to provide their customers with high-quality services, accurate results on time, and expert advice by their highly qualified staff.

Get Free Sample Here:

For More Information about each of these companies. Vantage Market Research Report comes up with a detailed analysis of each major player in the industry. The Study provides Global market size & share, Emerging trends, In-depth analysis of key players, Development opportunities, Sales, Revenue Forecast.